GlassScriptPhysician profile
Grace Lynn Su
NPI 1265994933
$3,172.83
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,038 · 2024: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,171 · Food and Beverage: $1,001 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,171.42 |
| Food and Beverage | $1,001.41 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,333.44 | 2023 | Crystalens Accommodating Iol (At-52ao), Envista Mx60 Iol, Stellaris Elite |
| Johnson & Johnson Surgical Vision, INC. | $524.60 | 2023 | Meibomian Gland Evaluator, Lipiflow System Activator (Disposable), Lipiview Ocular Surface Interferometer |
| Glaukos Corporation | $207.46 | 2023-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Rxsight INC | $76.78 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Abbvie INC. | $30.55 | 2023 | Durysta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.